This case highlights the importance of considering rare metabolic disorders such as <i>TCN2</i> deficiency in pediatric patients with unexplained anemia and neutropenia, and underscores the value of early recognition, genetic diagnosis, and long-term management. This evidence concerns the gene TCN2 and neutropenia.